CURX
NASDAQ · Pharmaceuticals
Curanex Pharmaceuticals Inc
$4.63
+0.26 (+5.95%)
Open$4.81
Previous Close$4.37
Day High$4.89
Day Low$4.40
52W High$173.60
52W Low$3.58
Volume—
Avg Volume33.2K
Market Cap6.74M
P/E Ratio—
EPS$-6.75
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.70M | 1.62M | 1.35M |
| Net Income | 499.2K | 484.2K | 288.0K |
| Profit Margin | 29.3% | 29.9% | 21.3% |
| EBITDA | 775.5K | 724.0K | 543.0K |
| Free Cash Flow | 289.5K | 292.3K | 286.4K |
| Rev Growth | +22.0% | +2.7% | +4.4% |
| Debt/Equity | 0.23 | 0.19 | 0.17 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |